Search Result "pegvisomant"
The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 24 Issue: 17 Year: 2024 Page: 11-11
Author(s):
The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 14 Issue: 3 Year: 2014 Page: 169-181
Author(s): Etual Espinosa,Claudia Ramirez,Moises Mercado
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 8 Year: 2020 Page: 1144-1155
Author(s): Renato Cozzi,Maria R. Ambrosio,Roberto Attanasio,Alessandro Bozzao,Laura De Marinis,Ernesto De Menis,Edoardo Guastamacchia,Andrea Lania,Giovanni Lasio,Francesco Logoluso,Pietro Maffei,Maurizio Poggi,Vincenzo Toscano,Michele Zini,Philippe Chanson,Laurence Katznelson
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 8 Year: 2020 Page: 1133-1143
Author(s): Renato Cozzi,Maria R. Ambrosio,Roberto Attanasio,Alessandro Bozzao,Laura De Marinis,Ernesto De Menis,Edoardo Guastamacchia,Andrea Lania,Giovanni Lasio,Francesco Logoluso,Pietro Maffei,Maurizio Poggi,Vincenzo Toscano,Michele Zini,Philippe Chanson,Laurence Katznelson
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 1 Year: 2009 Page: 54-72
Author(s): Madeleine Hewish, Ian Chau, David Cunningham
Clinical Pharmacology of Human Growth Hormone and its Secretagogues
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 2 Issue: 1 Year: 2002 Page: 27-52
Author(s): Allen W. Root, Michael J. Root
Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Journal: Current Drug Targets
Volume: 11 Issue: 9 Year: 2010 Page: 1121-1132
Author(s): Deepali Sachdev
Nanomedicine: Bioavailability, Biotransformation and Biokinetics
Journal: Current Drug Metabolism
Volume: 20 Issue: 7 Year: 2019 Page: 542-555
Author(s): Selvan Ravindran,Amlesh J. Tambe,Jitendra K. Suthar,Digamber S. Chahar,Joyleen M. Fernandes,Vedika Desai
Pharmacologic Therapy in Growth Hormone Disorders and the Heart
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 1399-1407
Author(s): Vicente Climent, Francisco Marin, Antonio Pico
GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 3 Year: 2005 Page: 277-291
Author(s): P. Dasgupta